International Patent: VIRUS EXPRESSING A MODIFIED E2 PROTEIN AND USES THEREOF, ESPECIALLY FOR SPECIFIC TARGETING OF ALPHA5BETA1-POSITIVE CANCER CELLS

GENEVA, Aug. 14 -- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE filed a patent application (EP2026/052719) for “VIRUS EXPRESSING A MODIFIED E2 PROTEIN AND USES THEREOF, ESPECIALLY FOR SPECIFIC TARGETING OF ALPHA5BETA1-POSITIVE CANCER CELLS”. With publication no. WO/2026/166942, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/005

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....